Cognition Therapeutics Inc (NASDAQ: CGTX) kicked off on Friday, up 4.32% from the previous trading day, before settling in for the closing price of $1.62. Over the past 52 weeks, CGTX has traded in a range of $0.22-$3.83.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -16.44%. While this was happening, its average annual earnings per share was recorded 54.65%. With a float of $80.16 million, this company’s outstanding shares have now reached $88.27 million.
Cognition Therapeutics Inc (CGTX) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Cognition Therapeutics Inc is 9.20%, while institutional ownership is 17.42%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Performance Highlights and Predictions
In the latest quarterly report, which was put into the public domain on 12/31/2024, the organization reported -0.17 earnings per share (EPS), lower than consensus estimate (set at -0.15) by -0.02. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.06 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 54.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.63% during the next five years compared to -16.44% drop over the previous five years of trading.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Take a look at Cognition Therapeutics Inc’s (CGTX) current performance indicators. Last quarter, stock had a quick ratio of 6.44.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.47, a number that is poised to hit -0.08 in the next quarter and is forecasted to reach -0.34 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
The latest stats from [Cognition Therapeutics Inc, CGTX] show that its last 5-days average volume of 0.86 million was inferior to 4.05 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 37.65%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 34.65%, which indicates a significant decrease from 72.09% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1199 in the past 14 days, which was lower than the 0.1988 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.6658, while its 200-day Moving Average is $1.0202. Now, the first resistance to watch is $1.7633. This is followed by the second major resistance level at $1.8367. The third major resistance level sits at $1.9133. If the price goes on to break the first support level at $1.6133, it is likely to go to the next support level at $1.5367. Assuming the price breaks the second support level, the third support level stands at $1.4633.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
The company with the Market Capitalisation of 149.18 million has total of 88,274K Shares Outstanding. Its annual sales at the moment are 0 K in contrast with the sum of -33,970 K annual income. Company’s last quarter sales were recorded 0 K and last quarter income was -4,930 K.
